CHIRON ACQUIRES CETUS THERAPEUTICS BUSINESS FOR ABOUT $ 360 MIL., LESS CETUS' PCR TECHNOLOGY; COMBINED PIPELINE HAS 22 PRODUCTS IN CLINICALS

More from Archive

More from Pink Sheet